Leukemia, Lymphocytic, Chronic, B-CellLeukemia, LymphoidPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemiaSurvival RateLeukemia, Myeloid, AcuteLeukemia, B-CellAsparaginaseCell SurvivalLeukemic InfiltrationSurvival AnalysisLeukemia, T-CellLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrognosisVidarabinePrecursor B-Cell Lymphoblastic Leukemia-LymphomaMethotrexateB-LymphocytesLeukemia, Biphenotypic, AcuteVincristineBone MarrowAntineoplastic AgentsTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsRemission, SpontaneousRemission InductionCytarabineLymphocytes, NullGene Expression Regulation, LeukemicDisease-Free Survival6-MercaptopurineImmunoglobulin Heavy ChainsLeukemia, ExperimentalLeukemia-Lymphoma, Adult T-CellLymphomaReceptors, Antigen, B-CellBurkitt LymphomaZAP-70 Protein-Tyrosine KinaseChlorambucilTime FactorsRetrospective StudiesLeukemia, Hairy CellRosette FormationDNA, NeoplasmRecurrenceCyclophosphamideKaryotypingChromosomes, Human, 6-12 and XPhiladelphia ChromosomeAnisocoriaLymphocytesCorneal PerforationTumor Cells, CulturedAntibodies, MonoclonalBlast CrisisAntigens, NeoplasmChromosome AberrationsLeukemia Virus, MurineAcute DiseaseT-LymphocytesCladribineTranslocation, GeneticDrug Resistance, NeoplasmPrednisoneLeukemia, MyeloidAntigens, CD5Fusion Proteins, bcr-ablApoptosisDNA NucleotidylexotransferaseAntigens, CD38Neoplasm ProteinsSurvivalMutationKaplan-Meier EstimateBone Marrow TransplantationNeoplasm StagingFollow-Up StudiesDrug Administration ScheduleGraft SurvivalImmunoglobulin Variable RegionFlow CytometryDaunorubicinChromosomes, Human, Pair 14NeprilysinSalvage TherapyDoxorubicinCell Line, TumorBase SequenceAntigens, SurfaceAntibodies, Monoclonal, Murine-DerivedTransplantation, HomologousMolecular Sequence DataRisk FactorsDexamethasoneCombined Modality TherapyPolymerase Chain ReactionLeukemia, Prolymphocytic, T-CellProto-Oncogene ProteinsImmunophenotypingCyclin-Dependent Kinase Inhibitor p15